Prior investigations have shown that SLE patients have an increase in the frequency of activated naïve B cells, which exhibit elevated levels of CD19, CD11c, and CD23 while displaying diminished expression of CD21, CD24, and CD38 [42]. The gene discussed is CD19; the disease is systemic lupus erythematosus.